The company faced headwinds in the December 2024 quarter (Q4) as it reported a significant decline in earnings.

Millie, a modern maternity clinic, secured $12 million in Series A funding led by existing investors RH Capital, TMV, ...

Following similar deals in countries like the United States and the U.K., Canada is bolstering its stockpile of bird flu ...

Previous bird flu outbreaks and decades-old public health infrastructure have led industry to protect the hens used for ...

Sanofi and CD&R sign Opella share purchase agreementParis, February 19, 2025. Following completion of the required social and corporate ...

Fifteen colleges would be affected by the executive order; K-12 schools nationwide no longer have such a requirement. Meanwhile, hospitals and medical providers are feeling the strain of the nation's ...

Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.

Valeo Financial Advisors LLC decreased its holdings in Sanofi (NASDAQ:SNY – Free Report) by 62.0% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund ...

CureVac N.V. (NASDAQ:CVAC), a biopharmaceutical company specializing in mRNA-based therapies and vaccines with a market ...

Sanofi and Johnson & Johnson’s E. coli vaccine candidate failed to prevent invasive E. coli disease effectively.

Sanofi Pasteur Inc., Swiftwater, Pennsylvania, has been awarded a maximum $25,058,635 firm-fixed-price, indefinite-quantity ...

Sanofi ( ($SNY) ) has provided an announcement. On February 13, 2025, Sanofi announced the discontinuation of the E.mbrace phase 3 study for its ...